To ensure that our original findings were not erroneous and indeed represented the actual frequency found in bladder and kidney cancer patients, we re-evaluated the frequency of the NOD2 c.3020insC allele and the p.A148T polymorphism in CDKN2A among 706 bladder cancer and 410 kidney cancer patients. Here, CDKN2A is linked to kidney cancer.